AlaskOmega is a product of Organic Technologies (Coshocton, OH).
The AlaskOmega line of omega-3 ingredients has received sustainability certification from the Marine Stewardship Council’s (MSC) Chain of Custody program. AlaskOmega includes concentrated ethyl esters, offering up to 85% omega-3s, and reconstituted triglyceride products. AlaskOmega is a product of Organic Technologies (Coshocton, OH).
AlaskOmega products are produced from the liver and viscera oils of pollock (Theragra chalcogramma), a member of the Gadidae cod family. The fish are caught wild in the Bering Sea/Aleutian Islands and the Gulf of Alaska. AlaskOmega products are then refined in the company’s GMP natural-products refinery in Coshocton, OH.
The company says that currently, 129 fisheries worldwide have been MSC-certified. It says that the U.S. Alaska Pollock fishery, where AlaskOmega fish are sourced, is the largest fishery in North America and one of the largest fisheries for human consumption worldwide.
“The oceans of the world are under pressure from commercial fishing to support human and animal nutritional needs,” says Organic Technologies vice president Dan Wiley. “Wild-caught fish, the last truly wild food, provides an important natural source of long-chain EPA and DHA omega-3 essential fatty acids (EFAs) that cannot be easily duplicated from vegetarian or agricultural sources.”
“Responsible sourcing of byproducts from a human-consumption fishery demonstrates a high level of stewardship and sustainability,” he adds. “We believe that sourcing raw oils from MSC-certified, 100% U.S.-sourced wild-caught fish for our AlaskOmega product line clearly communicates our commitment to provide the nutritional marketplace with a long-chain EPA and DHA omega-3 ingredient that meets the highest global standards for seafood sustainability.”
AlaskOmega concentrates are available in bulk 190-kg drums or 900-kg totes. The company says the oils exceed GOED and CRN monograph standards.
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.
FDA and FTC issue more warning letters to copycat delta-8 THC food products
July 16th 2024The U.S. Food and Drug Administration and Federal Trade Commission have jointly issued warning letters to five companies for selling copycat food products containing delta-8 THC in violation of the Federal Food Drug and Cosmetic Act.
Krill oil supplementation raises Omega-3 Index of Lupus patients in recent study
July 16th 2024The study was conducted at 20 research centers in the United States by Aker BioMarine and the Lupus Clinical Investigators Network with oversight by Lupus Therapeutics, the clinical research affiliate of the Lupus Research Alliance.